MED.00152 Outpatient Intravenous Insulin Therapy

This policy addresses outpatient intravenous insulin therapy (also called CIIIT, hepatic activation therapy, MAT, OIVIT, PIR, PIVIT, or PIT), which involves prolonged insulin infusions in an outpatient setting. Anthem deems this treatment investigational and not medically necessary for all indications, including diabetes; therefore, it is not covered. There are no covered exceptions or indications under this policy; related billing code: G9147.

"Outpatient intravenous insulin therapy is consideredinvestigational and not medically necessaryas a treatment for all indications, including diabetes."

Sign up to see full coverage criteria, indications, and limitations.